2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide (SarCNU) Summary

24 relevant articles (3 outcomes, 9 trials/studies) found for this Bio-Agent

Key Diseases for which 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide is Relevant

1. Neoplasms (Cancer) : 2 outcomes 2 studies in 11 results
   
2. Glioma (Gliomas) : 1 outcome 4 studies in 16 results
   
3. Hepatocellular Carcinoma (Hepatoma) : 1 outcome 1 study in 2 results
   
4. Carcinoma (Carcinomatosis) : 2 studies in 2 results
   
5. Colorectal Neoplasms (Colorectal Cancer) : 1 study in 1 result
   

Drugs Related to 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide

1. Carmustine (FIVB)
2. M-2 protocol (M 2)
3. 1-(2-chloroethyl)-1-nitrosourea (CNU)
4. N-methylglycinamide
5. Catecholamine Plasma Membrane Transport Proteins
6. Norepinephrine (Noradrenaline)
7. Amino Acids
8. 2'- (2- hydroxyphenyl)- 2'- thiazoline- 4'- carboxylic acid
9. N-chloroethylnitrosourea asparaginamide
10. lissamine rhodamine B (sulforhodamine B)

Therapies Related to 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide

1. Heterologous Transplantation (Xenotransplantation)
2. Transplants (Transplant)
3. Drug Therapy (Chemotherapy)